StockTipsArenaBeta

BUY Max Healthcare Institute Limited — Sharad Avasthi, SMIFS

BUYMax Healthcare Institute Limited
Max Healthcare Institute share price target & all analyst calls

bySharad Avasthi, SMIFSHorizon: 1 year26 Oct 2026via CNBC Awaaz.

Entry₹840.4Inferred
Target₹1,000
Total upside +18.99%
Stop lossNot given
CMP₹947.11d ago
Active+12.70%+5.59%upside left 12 mo left
Follow Sharad Avasthi for new callsGet alertsWatch MAXHEALTH for new buy/sell callsGet alertsSee 27 other Long-term calls on MAXHEALTHSee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:33 am IST
16 supporting12 neutral7 opposing
Supports the BUY call (16)

Max Healthcare (NSE:MAXHEALTH) Q2 FY27: Revenue Up 20%, PAT Up 10%

NewsGoogle News·10 Nov · 4d ago

(opens in new tab)

Max Healthcare Q2FY27 PAT rises 10% to ₹448 crore on 20% revenue growth

NewsGoogle News·9 Nov · 5d ago

(opens in new tab)

Max Healthcare Institute Ltd Revenue Rises 20% to Rs 3,219 Crore

NewsGoogle News·9 Nov · 5d ago

(opens in new tab)

17 other SEBI-registered advisors have active long-term BUY calls on this stock, with 8 issued in the last 14 days

Advisor consensus · same horizon·4 Nov · 1w ago

Max Healthcare reported Q2 revenue of Rs. 3,219 crore, a 20% year-on-year increase, and a profit after tax of Rs. 448 crore, representing 10% year-on-year growth.

BSE · Company Update·30 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (12)

Nothing found in this tip’s window yet.

Weighs against the BUY call (7)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·13 Nov · yesterday

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·13 Oct · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Max Healthcare Institute

All analyst calls on Max Healthcare Institute

More from Sharad Avasthi, SMIFS

Every call and its outcome